CVE-2008-0998

Description

Unspecified vulnerability in NetCfgTool in the System Configuration component in Apple Mac OS X 10.4.11 and 10.5.2 allows local users to bypass authorization and execute arbitrary code via crafted distributed objects.

Category

6.9
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.06%
Vendor Advisory apple.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/28304 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/41281 vdb entry
http://www.us-cert.gov/cas/techalerts/TA08-079A.html third party advisory us government resource
http://www.vupen.com/english/advisories/2008/0924/references vdb entry
http://secunia.com/advisories/29420 third party advisory
http://lists.apple.com/archives/security-announce/2008/Mar/msg00001.html patch vendor advisory
http://www.securityfocus.com/bid/28385 vdb entry
http://docs.info.apple.com/article.html?artnum=307562
http://www.securitytracker.com/id?1019674 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-0998?
CVE-2008-0998 has been scored as a medium severity vulnerability.
How to fix CVE-2008-0998?
To fix CVE-2008-0998, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-0998 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2008-0998 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.